Wu Yiling Biography
Wu Yiling is a Chinese billionaire who chairs Yiling Pharmaceutical, which makes cardiovascular and flu drugs, among others. The company was founded by his father in 1992
How old is Wu Yiling? – Age
He is 72 years old as of 2021. He was born in 1949 in Hebei, China.
Wu Yiling Family
His father was a medical professional while his mother was a housekeeper.
Wu Yiling Wife
He is married and the couple has two children.
Wu Yiling Education
Dr. Wu earned her medical degree from Zhejiang University in 2004, and her medical master’s degree from Zhejiang University in 2013. Dr. Wu completed her pediatric residency in 2006 at Hangzhou First People’s Hospital, where she treated patients and gained expertise in conditions ranging from growth development to child nutrition.
Wu Yiling Net Worth
He has an estimated net worth of $2.3 billion. His company is listed on the Shenzhen Stock Exchange.
Yiling Pharmaceutical is a Chinese company primarily engaged in pharmaceutical research and development, manufacturing, and distribution. The company primarily sells cardiovascular and cerebrovascular drugs, as well as anti-cold medications. In addition, the company sells food and beverages. The company distributes its products both domestically and internationally.
Dr. Wu has more than a decade of clinical experience. Dr. Wu previously worked at Hangzhou First People’s Hospital as a specialist in Growth and Development, Nutrition, and Psychology, and Behavioral problems. Dr. Wu has published in medical journals, including the Chinese Journal of Child Health Care, in addition to her clinical work.
Tu was awarded the Nobel Prize in Medicine in 2015 for her contribution to the effective use of artemisinin, a key component of anti-malarial drugs. However, the practitioner of traditional Chinese medicine (TCM) missed out on billions of dollars in patent income (see WiC299). That hasn’t been the case for Wu Yiling, arguably the wealthiest TCM expert, who developed Lianhua Qingwen, a patented drug that Chinese authorities believe is effective in treating coronaviruses (see this week’s “Talking Point”).